文献速递功能神经外科

三叉神经痛放射外科治疗的前方选择性靶点:一项队列研究

Anterior selective targeting for radiosurgical treatment of trigeminal neuralgia: a cohort study.
PubMed 文献 · Acta Neurochir (Wien) · 2024-11-28

该单中心队列研究纳入2019年2月至2022年6月接受放射外科治疗的三叉神经痛患者66例,比较前方选择性靶点(AST,n=25)与经典靶点REZ(n=21)、RGZ(n=20)的疗效与安全性。所有组疼痛均显著改善且组间结果相似,AST的束流时间显著更短、脑干剂量显著更低,作者认为AST在初步研究中与经典靶点疗效安全性相当。

要点

  • AST组(n=25)与REZ组(n=21)、RGZ组(n=20)疼痛改善均显著且组间结果相似。
  • AST治疗的束流时间显著更短,脑干剂量显著更低。
  • AST无需阻断保护脑干,作者认为可用于选定患者并可在更大研究中作为替代方案研究。

核心结论

  • 在此初步研究中,AST与经典靶点结果相当,在疗效和安全性上无 superiority 或 inferiority 的迹象。
  • 由于该方法无需阻断保护脑干,可根据需要用于选定患者,并可在更大研究中作为替代方案进行研究。

研究设计与样本

  • 单中心队列研究,纳入2019年2月至2022年6月接受放射外科治疗的三叉神经痛患者。
  • 共纳入66例患者,分为REZ组(n=21)、RGZ组(n=20)和AST组(n=25)。
  • 在1周、1-3-6个月和1年时比较疼痛缓解、药物依赖和副作用特征。

主要发现

  • 所有组均显示疼痛显著改善,组间结果相似。
  • AST治疗的束流时间显著更短,脑干剂量显著更低。

临床怎么用

  • 作者认为AST无需阻断保护脑干,可根据需要用于选定患者。
  • 作者认为AST可在更大研究中作为替代方案进行研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Before commonly used targets such as the Retrogasserian Zone (RGZ) and the Root Entry Zone (REZ) were adopted for the radiosurgical treatment of trigeminal neuralgia (TN), a more anterior target involving the Gasserian ganglion was used. Thanks to advancements in imaging technology, it is now possible to identify and target separate nerve divisions in Meckel's Cave as desired. Although this approach has been mentioned previously, no clinical study has investigated it until now. This study aims to fill this gap in the literature. METHODS: Trigeminal neuralgia patients who received radiosurgical treatment between February 2019 and June 2022 in a single centre were included in the study. Pain relief, medication dependency and side effect profiles of the investigated anterior selective target (AST) were compared to those of the classical targets at 1 week, 1-3-6 months, and 1 year. RESULTS: A total of 66 patients were included in the study. Effectiveness, safety and application convenience parameters were compared between; the REZ (n = 21), RGZ (n = 20) and AST (n = 25) groups. All groups showed significant improvement in pain with similar results to each other. AST treatments were performed in significantly shorter beam-on-times and with significantly lower brainstem doses. CONCLUSIONS: The investigated AST showed comparable results to the classical targets without any indication of superiority or inferiority in terms of efficacy and safety in this preliminary investigation. As no blocks were needed to protect the brainstem with this method, it can be used for select patients as needed and could even be investigated in larger studies as an alternative approach.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Sozer A, Tufek OY, Sahin MB, et al. Anterior selective targeting for radiosurgical treatment of trigeminal neuralgia: a cohort study. Acta Neurochir (Wien). 2024. PMID: 39604654. doi:10.1007/s00701-024-06365-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。